Fund profile
Fund manager
Total assets
$185.97 mm
Liabilities
$2.40 mm
Net assets
$183.58 mm
Number of holdings
189.00
189 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
UNH Unitedhealth Group Inc | 14.84 mm | 28.19 k shares | 8.08 | Common equity | Long | USA |
LLY Lilly(Eli) & Co | 14.77 mm | 25.34 k shares | 8.05 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 8.74 mm | 16.47 k shares | 4.76 | Common equity | Long | USA |
ISRG Intuitive Surgical Inc | 7.04 mm | 20.88 k shares | 3.84 | Common equity | Long | USA |
ELV Elevance Health Inc | 6.52 mm | 13.83 k shares | 3.55 | Common equity | Long | USA |
MRK Merck & Co Inc | 6.47 mm | 59.38 k shares | 3.53 | Common equity | Long | USA |
SYK Stryker Corp. | 5.99 mm | 19.99 k shares | 3.26 | Common equity | Long | USA |
DHR Danaher Corp. | 5.12 mm | 22.11 k shares | 2.79 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 5.04 mm | 12.39 k shares | 2.75 | Common equity | Long | USA |
AstraZeneca plc
|
3.68 mm | 54.57 k shares | 2.00 | Common equity | Long | UK |
AMGN AMGEN Inc. | 3.63 mm | 12.62 k shares | 1.98 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 3.47 mm | 3.95 k shares | 1.89 | Common equity | Long | USA |
ARGX Argen X SE | 3.44 mm | 9.04 k shares | 1.87 | Common equity | Long | Netherlands |
MOH Molina Healthcare Inc | 3.32 mm | 9.20 k shares | 1.81 | Common equity | Long | USA |
HUM Humana Inc. | 2.86 mm | 6.25 k shares | 1.56 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 2.80 mm | 14.61 k shares | 1.52 | Common equity | Long | USA |
PEN Penumbra Inc | 2.46 mm | 9.79 k shares | 1.34 | Common equity | Long | USA |
BDX Becton Dickinson & Co. | 2.38 mm | 9.74 k shares | 1.29 | Common equity | Long | USA |
Cigna Holding Co | 2.31 mm | 7.73 k shares | 1.26 | Common equity | Long | USA |
A Agilent Technologies Inc. | 2.24 mm | 16.10 k shares | 1.22 | Common equity | Long | USA |
NVO Novo Nordisk | 2.03 mm | 19.62 k shares | 1.11 | Common equity | Long | Denmark |
KRTX Karuna Therapeutics Inc | 1.95 mm | 6.15 k shares | 1.06 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 1.83 mm | 19.79 k shares | 0.99 | Common equity | Long | USA |
Immunocore Holdings plc
|
1.72 mm | 25.18 k shares | 0.94 | Common equity | Long | UK |
HCA HCA Healthcare Inc | 1.60 mm | 5.92 k shares | 0.87 | Common equity | Long | USA |
CNC Centene Corp. | 1.59 mm | 21.41 k shares | 0.87 | Common equity | Long | USA |
WST West Pharmaceutical Services, Inc. | 1.47 mm | 4.16 k shares | 0.80 | Common equity | Long | USA |
BeiGene Ltd.
|
1.36 mm | 7.55 k shares | 0.74 | Common equity | Long | Cayman Islands |
BSX Boston Scientific Corp. | 1.36 mm | 23.49 k shares | 0.74 | Common equity | Long | USA |
EW Edwards Lifesciences Corp | 1.36 mm | 17.80 k shares | 0.74 | Common equity | Long | USA |
DXCM Dexcom Inc | 1.31 mm | 10.56 k shares | 0.71 | Common equity | Long | USA |
HOLX Hologic, Inc. | 1.31 mm | 18.27 k shares | 0.71 | Common equity | Long | USA |
ABBV Abbvie Inc | 1.27 mm | 8.21 k shares | 0.69 | Common equity | Long | USA |
ZTS Zoetis Inc - Ordinary Shares | 1.27 mm | 6.42 k shares | 0.69 | Common equity | Long | USA |
ABMD Abiomed Inc | 1.16 mm | 6.11 k shares | 0.63 | Common equity | Long | USA |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 1.14 mm | 11.87 k shares | 0.62 | Common equity | Long | USA |
LEGN Legend Biotech Corp | 1.10 mm | 18.28 k shares | 0.60 | Common equity | Long | Cayman Islands |
BIIB Biogen Inc | 1.08 mm | 4.16 k shares | 0.59 | Common equity | Long | USA |
TXG 10x Genomics Inc - Ordinary Shares | 1.01 mm | 18.02 k shares | 0.55 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals Inc | 1.00 mm | 16.76 k shares | 0.55 | Common equity | Long | USA |
VEEV Veeva Systems Inc - Ordinary Shares | 945.08 k | 4.91 k shares | 0.51 | Common equity | Long | USA |
EXAS Exact Sciences Corp. | 943.84 k | 12.76 k shares | 0.51 | Common equity | Long | USA |
Biohaven Ltd.
|
905.56 k | 21.16 k shares | 0.49 | Common equity | Long | Virgin Islands (British) |
BLACKROCK LIQUIDITY FEDFUND OPEN-END FUND USD | 897.92 k | 897.92 k principal | 0.49 | Short-term investment vehicle | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 867.11 k | 6.58 k shares | 0.47 | Common equity | Long | USA |
INSM Insmed Inc | 856.28 k | 27.63 k shares | 0.47 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 844.75 k | 16.70 k shares | 0.46 | Common equity | Long | USA |
CYTK Cytokinetics Inc | 840.33 k | 10.07 k shares | 0.46 | Common equity | Long | USA |
Sartorius AG (Preference)
|
830.21 k | 2.26 k shares | 0.45 | Common equity | Long | Germany |
MLTX MoonLake Immunotherapeutics - Ordinary Shares | 809.71 k | 13.41 k shares | 0.44 | Common equity | Long | Cayman Islands |
PODD Insulet Corporation | 804.34 k | 3.71 k shares | 0.44 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 774.97 k | 16.21 k shares | 0.42 | Common equity | Long | USA |
TFX Teleflex Incorporated | 766.97 k | 3.08 k shares | 0.42 | Common equity | Long | USA |
AVTR Avantor Inc. | 745.35 k | 32.65 k shares | 0.41 | Common equity | Long | USA |
MCK Mckesson Corporation | 725.49 k | 1.57 k shares | 0.40 | Common equity | Long | USA |
ICON plc
|
715.60 k | 2.53 k shares | 0.39 | Common equity | Long | Ireland |
CTLT Catalent Inc. | 712.86 k | 15.87 k shares | 0.39 | Common equity | Long | USA |
BRKR Bruker Corp | 703.79 k | 9.58 k shares | 0.38 | Common equity | Long | USA |
RGEN Repligen Corp. | 696.01 k | 3.87 k shares | 0.38 | Common equity | Long | USA |
DREYFUS TREASURY OBLIGATIONS CASH MANAGEMENT FUND OPEN-END FUND USD | 694.29 k | 694.29 k principal | 0.38 | Short-term investment vehicle | Long | USA |
PCVX Vaxcyte Inc | 642.19 k | 10.23 k shares | 0.35 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 623.61 k | 6.47 k shares | 0.34 | Common equity | Long | USA |
ZBH Zimmer Biomet Holdings Inc | 591.58 k | 4.86 k shares | 0.32 | Common equity | Long | USA |
RVMD Revolution Medicines Inc | 577.84 k | 20.15 k shares | 0.31 | Common equity | Long | USA |
IQV IQVIA Holdings Inc | 568.04 k | 2.46 k shares | 0.31 | Common equity | Long | USA |
ACAD Acadia Pharmaceuticals Inc | 521.78 k | 16.67 k shares | 0.28 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corp | 513.47 k | 27.31 k shares | 0.28 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics Inc | 503.70 k | 13.80 k shares | 0.27 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 503.67 k | 4.00 k shares | 0.27 | Common equity | Long | Denmark |
GOLDMAN SACHS FINANCIAL SQUARE GOVERNMENT FUND OPEN-END FUND | 500.00 k | 500.00 k principal | 0.27 | Short-term investment vehicle | Long | USA |
ARVN Arvinas Inc | 497.30 k | 12.08 k shares | 0.27 | Common equity | Long | USA |
Zai Lab Ltd.
|
493.58 k | 18.06 k shares | 0.27 | Common equity | Long | Cayman Islands |
TECH Bio-Techne Corp | 490.51 k | 6.36 k shares | 0.27 | Common equity | Long | USA |
LNTH Lantheus Holdings Inc | 476.90 k | 7.69 k shares | 0.26 | Common equity | Long | USA |
PRCT Procept BioRobotics Corp | 467.09 k | 11.15 k shares | 0.25 | Common equity | Long | USA |
THC Tenet Healthcare Corp. | 465.81 k | 6.16 k shares | 0.25 | Common equity | Long | USA |
COR Cencora Inc. | 459.85 k | 2.24 k shares | 0.25 | Common equity | Long | USA |
Roivant Sciences Ltd.
|
445.93 k | 39.71 k shares | 0.24 | Common equity | Long | Bermuda |
Genmab A/S
|
444.23 k | 1.39 k shares | 0.24 | Common equity | Long | Denmark |
SGRY Surgery Partners Inc | 428.31 k | 13.39 k shares | 0.23 | Common equity | Long | USA |
RLAY Relay Therapeutics Inc | 427.10 k | 38.79 k shares | 0.23 | Common equity | Long | USA |
CAH Cardinal Health, Inc. | 419.33 k | 4.16 k shares | 0.23 | Common equity | Long | USA |
CRL Charles River Laboratories International Inc. | 412.28 k | 1.74 k shares | 0.22 | Common equity | Long | USA |
Prothena Corp. plc
|
411.19 k | 11.32 k shares | 0.22 | Common equity | Long | Ireland |
INCY Incyte Corp. | 410.02 k | 6.53 k shares | 0.22 | Common equity | Long | USA |
MASI Masimo Corp | 408.36 k | 3.48 k shares | 0.22 | Common equity | Long | USA |
KRYS Krystal Biotech Inc | 404.44 k | 3.26 k shares | 0.22 | Common equity | Long | USA |
CFRXQ CONTRAFECT Corp | 403.50 k | 41.13 k shares | 0.22 | Common equity | Long | USA |
AGL Agilon Health Inc | 402.98 k | 32.11 k shares | 0.22 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals Inc | 401.87 k | 13.41 k shares | 0.22 | Common equity | Long | USA |
EXEL Exelixis Inc | 400.94 k | 16.71 k shares | 0.22 | Common equity | Long | USA |
Royalty Pharma plc, Class A
|
387.56 k | 13.80 k shares | 0.21 | Common equity | Long | UK |
IDYA Ideaya Biosciences Inc | 384.51 k | 10.81 k shares | 0.21 | Common equity | Long | USA |
Daiichi Sankyo Co. Ltd.
|
384.45 k | 14.00 k shares | 0.21 | Common equity | Long | Japan |
CRNX Crinetics Pharmaceuticals Inc | 377.79 k | 10.62 k shares | 0.21 | Common equity | Long | USA |
Sonova Holding AG (Registered)
|
375.85 k | 1.15 k shares | 0.20 | Common equity | Long | Switzerland |
GPCR Structure Therapeutics Inc | 373.40 k | 9.16 k shares | 0.20 | Common equity | Long | Cayman Islands |
ITCI Intra-Cellular Therapies Inc | 372.71 k | 5.20 k shares | 0.20 | Common equity | Long | USA |
KYMR Kymera Therapeutics Inc | 350.25 k | 13.76 k shares | 0.19 | Common equity | Long | USA |
CRGX CARGO Therapeutics Inc | 335.65 k | 14.50 k shares | 0.18 | Common equity | Long | USA |
NUVL Nuvalent Inc - Ordinary Shares | 333.07 k | 4.53 k shares | 0.18 | Common equity | Long | USA |
SDGR Schrodinger Inc | 313.64 k | 8.76 k shares | 0.17 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals Inc | 313.52 k | 1.36 k shares | 0.17 | Common equity | Long | USA |
GH Guardant Health Inc | 298.15 k | 11.02 k shares | 0.16 | Common equity | Long | USA |
CBAY Cymabay Therapeutics Inc | 296.69 k | 12.56 k shares | 0.16 | Common equity | Long | USA |
Novocure Ltd.
|
285.40 k | 19.12 k shares | 0.16 | Common equity | Long | Jersey |
Pharvaris NV
|
282.07 k | 10.06 k shares | 0.15 | Common equity | Long | Netherlands |
ILMN Illumina Inc | 279.04 k | 2.00 k shares | 0.15 | Common equity | Long | USA |
ACLX Arcellx Inc | 276.11 k | 4.98 k shares | 0.15 | Common equity | Long | USA |
CRISPR Therapeutics AG
|
267.30 k | 4.27 k shares | 0.15 | Common equity | Long | Switzerland |
RAPT RAPT Therapeutics Inc | 257.77 k | 10.37 k shares | 0.14 | Common equity | Long | USA |
EYPT EyePoint Pharmaceuticals Inc | 256.73 k | 11.11 k shares | 0.14 | Common equity | Long | USA |
XNCR Xencor Inc | 249.94 k | 11.77 k shares | 0.14 | Common equity | Long | USA |
PTGX Protagonist Therapeutics Inc | 245.35 k | 10.70 k shares | 0.13 | Common equity | Long | USA |
ZNTL Zentalis Pharmaceuticals Inc | 235.37 k | 15.54 k shares | 0.13 | Common equity | Long | USA |
CLDX Celldex Therapeutics Inc. | 234.47 k | 5.91 k shares | 0.13 | Common equity | Long | USA |
Astellas Pharma, Inc.
|
233.17 k | 19.50 k shares | 0.13 | Common equity | Long | Japan |
IRTC iRhythm Technologies Inc | 232.60 k | 2.17 k shares | 0.13 | Common equity | Long | USA |
MORF Morphic Holding Inc | 230.95 k | 8.00 k shares | 0.13 | Common equity | Long | USA |
APGE Apogee Therapeutics Inc. | 229.92 k | 8.23 k shares | 0.13 | Common equity | Long | USA |
GKOS Glaukos Corporation | 228.93 k | 2.88 k shares | 0.12 | Common equity | Long | USA |
PRVA Privia Health Group Inc | 227.61 k | 9.88 k shares | 0.12 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics Inc | 225.49 k | 27.74 k shares | 0.12 | Common equity | Long | USA |
BAX Baxter International Inc. | 220.25 k | 5.70 k shares | 0.12 | Common equity | Long | USA |
AMAM Ambrx Biopharma Inc. | 213.87 k | 15.02 k shares | 0.12 | Common equity | Long | USA |
RNA Avidity Biosciences Inc | 210.59 k | 23.27 k shares | 0.11 | Common equity | Long | USA |
AKRO Akero Therapeutics Inc | 208.10 k | 8.91 k shares | 0.11 | Common equity | Long | USA |
IMVT Immunovant Inc | 205.64 k | 4.88 k shares | 0.11 | Common equity | Long | USA |
INSP Inspire Medical Systems Inc | 200.99 k | 988.00 shares | 0.11 | Common equity | Long | USA |
PTCT PTC Therapeutics Inc | 198.98 k | 7.22 k shares | 0.11 | Common equity | Long | USA |
MOR Morphosys AG | 195.95 k | 19.79 k shares | 0.11 | Common equity | Long | Germany |
PLRX Pliant Therapeutics Inc | 190.52 k | 10.52 k shares | 0.10 | Common equity | Long | USA |
LYEL Lyell Immunopharma Inc | 187.69 k | 96.75 k shares | 0.10 | Common equity | Long | USA |
REPL Replimune Group Inc | 185.37 k | 21.99 k shares | 0.10 | Common equity | Long | USA |
Alkermes plc
|
184.42 k | 6.65 k shares | 0.10 | Common equity | Long | Ireland |
SAGE Sage Therapeutics Inc | 183.72 k | 8.48 k shares | 0.10 | Common equity | Long | USA |
ALHC Alignment Healthcare Inc | 173.81 k | 20.19 k shares | 0.09 | Common equity | Long | USA |
IMRX Immuneering Corp - Ordinary Shares | 165.59 k | 22.53 k shares | 0.09 | Common equity | Long | USA |
NTLA Intellia Therapeutics Inc | 164.34 k | 5.39 k shares | 0.09 | Common equity | Long | USA |
Immatics NV
|
163.23 k | 15.50 k shares | 0.09 | Common equity | Long | Netherlands |
DNLI Denali Therapeutics Inc | 162.82 k | 7.59 k shares | 0.09 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals Inc | 161.42 k | 5.47 k shares | 0.09 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals Inc | 157.36 k | 7.07 k shares | 0.09 | Common equity | Long | USA |
BCYC Bicycle Therapeutics Plc | 144.06 k | 7.97 k shares | 0.08 | Common equity | Long | UK |
RYTM Rhythm Pharmaceuticals Inc. | 135.01 k | 2.94 k shares | 0.07 | Common equity | Long | USA |
ARDX Ardelyx Inc | 133.94 k | 21.60 k shares | 0.07 | Common equity | Long | USA |
Evotec SE
|
130.45 k | 5.55 k shares | 0.07 | Common equity | Long | Germany |
OSCR Oscar Health Inc - Ordinary Shares | 128.10 k | 14.00 k shares | 0.07 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals Inc | 126.51 k | 8.67 k shares | 0.07 | Common equity | Long | USA |
SANA Sana Biotechnology Inc | 125.55 k | 30.77 k shares | 0.07 | Common equity | Long | USA |
TRDA Entrada Therapeutics Inc | 123.21 k | 8.17 k shares | 0.07 | Common equity | Long | USA |
ALLO Allogene Therapeutics Inc | 122.86 k | 38.27 k shares | 0.07 | Common equity | Long | USA |
WaVe Life Sciences Ltd.
|
122.35 k | 24.23 k shares | 0.07 | Common equity | Long | Singapore |
AMLX Amylyx Pharmaceuticals Inc | 120.70 k | 8.20 k shares | 0.07 | Common equity | Long | USA |
IMNM Immunome Inc | 117.22 k | 10.96 k shares | 0.06 | Common equity | Long | USA |
GLUE Monte Rosa Therapeutics Inc | 115.62 k | 20.46 k shares | 0.06 | Common equity | Long | USA |
PRME Prime Medicine Inc | 111.41 k | 12.57 k shares | 0.06 | Common equity | Long | USA |
IRON Disc Medicine Inc | 110.61 k | 1.92 k shares | 0.06 | Common equity | Long | USA |
CABA Cabaletta Bio Inc | 108.96 k | 4.80 k shares | 0.06 | Common equity | Long | USA |
ALEC Alector Inc | 102.57 k | 12.85 k shares | 0.06 | Common equity | Long | USA |
VYGR Voyager Therapeutics Inc | 102.31 k | 12.12 k shares | 0.06 | Common equity | Long | USA |
CNTA Centessa Pharmaceuticals plc | 101.84 k | 12.79 k shares | 0.06 | Common equity | Long | UK |
Pharming Group NV
|
101.05 k | 88.79 k shares | 0.06 | Common equity | Long | Netherlands |
DNA Ginkgo Bioworks Holdings Inc - Ordinary Shares | 91.03 k | 53.86 k shares | 0.05 | Common equity | Long | USA |
ENOV Enovis Corp | 89.63 k | 1.60 k shares | 0.05 | Common equity | Long | USA |
AXSM Axsome Therapeutics Inc | 87.55 k | 1.10 k shares | 0.05 | Common equity | Long | USA |
OBIO Orchestra BioMed Holdings Inc | 82.59 k | 9.05 k shares | 0.04 | Common equity | Long | USA |
IGMS IGM Biosciences Inc | 81.11 k | 9.76 k shares | 0.04 | Common equity | Long | USA |
ALXO Alx Oncology Holdings Inc | 74.45 k | 5.00 k shares | 0.04 | Common equity | Long | USA |
TNYA Tenaya Therapeutics Inc | 70.03 k | 21.61 k shares | 0.04 | Common equity | Long | USA |
AURA Aura Biosciences Inc | 64.65 k | 7.30 k shares | 0.04 | Common equity | Long | USA |
AUTL Autolus Therapeutics plc | 62.22 k | 9.66 k shares | 0.03 | Common equity | Long | UK |
MorphoSys AG
|
53.71 k | 1.43 k shares | 0.03 | Common equity | Long | Germany |
ORIC ORIC Pharmaceuticals Inc | 52.44 k | 5.70 k shares | 0.03 | Common equity | Long | USA |
LBPH Longboard Pharmaceuticals Inc | 50.64 k | 8.40 k shares | 0.03 | Common equity | Long | USA |
GBIO Generation Bio Co | 49.73 k | 30.14 k shares | 0.03 | Common equity | Long | USA |
ALPN Alpine Immune Sciences Inc | 49.56 k | 2.60 k shares | 0.03 | Common equity | Long | USA |
ALLK Allakos Inc | 48.01 k | 17.59 k shares | 0.03 | Common equity | Long | USA |
ANAB AnaptysBio Inc | 47.12 k | 2.20 k shares | 0.03 | Common equity | Long | USA |
PRLD Prelude Therapeutics Inc | 43.75 k | 10.25 k shares | 0.02 | Common equity | Long | USA |
CCCC C4 Therapeutics Inc | 41.25 k | 7.30 k shares | 0.02 | Common equity | Long | USA |
ANTX AN2 Therapeutics Inc | 36.88 k | 1.80 k shares | 0.02 | Common equity | Long | USA |
GOSS Gossamer Bio Inc | 32.49 k | 35.60 k shares | 0.02 | Common equity | Long | USA |
INVESCO GOVERNMENT & AGENCY PORTFOLIO OPEN-END FUND USD | 28.73 k | 28.73 k principal | 0.02 | Short-term investment vehicle | Long | USA |
TSHA Taysha Gene Therapies Inc | 21.42 k | 12.10 k shares | 0.01 | Common equity | Long | USA |
WGS GeneDx Holdings Corp - Ordinary Shares | 2.05 k | 744.00 shares | 0.00 | Common equity | Long | USA |
RVMD Revolution Medicines Inc | 1.03 k | 3.13 k shares | 0.00 | DO | N/A | USA |
SLGC SomaLogic, Inc. | 170.16 | 1.42 k shares | 0.00 | DO | N/A | USA |
WGS GeneDx Holdings Corp - Ordinary Shares | 39.65 | 3.33 k shares | 0.00 | DO | N/A | USA |